Skip to main content

Table 5 Estimates of prevalence of high triglycerides levels and hypercholesterolemia among Iranian adults 25–64 years old

From: Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia

  Triglycerides ≥ 150 mg/dl Cholesterol ≥ 200 mg/dl Cholesterol ≥ 240 mg/dl
  National
estimatea
Prevalence
(95% CI)
National
estimatea
Prevalence
(95% CI)
National
estimatea
Prevalence
(95% CI)
Age       
   25–34 (n = 843) 3.5 27.1 (23.7–30.7) 3.9 30.2 (26.8–33.7) 1.1 8.8 (6.6–11.6)
   35–44 (n = 902) 3.8 42.4 (37.4–47.7) 4.2 46.2 (42.5–50.0) 1.3 14.2 (11.4–17.6)
   45–54 (n = 869) 2.7 42.6 (39.3–45.9) 3.4 54.0 (50.3–57.7) 1.2 19.0 (16.6–21.6)
   55–64 (n = 783) 1.5 44.5 (40.7–48.4) 2.1 61.6 (56.3–66.6) 0.8 25.4 (21.7–29.5)
Sex       
   Males (n = 1645) 6.3 39.6 (36.0–43.3) 6.4 40.4 (36.8–44.2) 1.8 11.0 (9.0–13.4)
   Females (n = 1752) 5.1 33.2 (30.3–36.2) 7.0 45.4 (42.1–48.7) 2.7 17.3 (15.1–19.8)
Residential area       
   Urban (n = 2175) 8.8 39.3 (36.4–42.2) 9.9 44.2 (41.4–47.0) 3.2 14.4 (12.7–16.4)
   Rural (n = 1222) 2.6 29.3 (26.1–32.8) 3.5 39.6 (34.7–44.6) 1.2 13.4 (10.3–17.3)
Total national estimate
(n = 3397)
11.4 36.4 (34.1–38.9) 13.5 42.9 (40.4–45.4) 4.4 14.1 (12.6–15.9)
  1. CI: confidence interval
  2. a Rounded to the nearest million
  3. Estimates are weighted for age, sex, and residential area on the basis of the population of Iran in 2006 Iran